• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royalty Pharma plc - Class A Ordinary Shares (NQ:RPRX)

40.26 UNCHANGED
Streaming Delayed Price Updated: 4:15 PM EST, Jan 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 332
Open 40.26
Bid (Size) 39.00 (100)
Ask (Size) 41.60 (100)
Prev. Close 40.26
Today's Range 40.26 - 40.26
52wk Range 25.77 - 41.70
Shares Outstanding 388,132,400
Dividend Yield 2.19%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Royalty Pharma Announces Dividend Increase
Today 8:30 EST
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Branded Pharmaceuticals Stocks Q3 Results: Benchmarking Royalty Pharma (NASDAQ:RPRX)
January 07, 2026
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with... 
Via StockStory
Topics Artificial Intelligence Intellectual Property

Performance

YTD
+3.6%
+3.6%
1 Month
+5.7%
+5.7%
3 Month
+11.4%
+11.4%
6 Month
+11.5%
+11.5%
1 Year
+53.7%
+53.7%

More News

Read More
News headline image
3 Overrated Stocks We Steer Clear Of
December 31, 2025
Via StockStory
News headline image
Royalty Pharma Acquires Remaining Royalty Interest in Roche’s Evrysdi for $240 Million and Potential Milestones
December 29, 2025
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Earnings Scheduled For November 5, 2025 ↗
November 05, 2025
Via Benzinga
News headline image
3 Healthcare Stocks We’re Skeptical Of
December 16, 2025
Via StockStory
Topics Stocks
News headline image
Royalty Pharma Acquires Royalty Interest in Nuvalent’s Neladalkib and Zidesamtinib for Up to $315 Million
December 16, 2025
From Royalty Pharma plc
Via GlobeNewswire
News headline image
What's going on in today's after hours session ↗
December 08, 2025
Via Chartmill
News headline image
Royalty Pharma PLC-CL A (NASDAQ:RPRX) Shows Strong Technical Setup for a Breakout ↗
December 06, 2025
Via Chartmill
News headline image
Royalty Pharma and Denali Therapeutics Announce $275 Million Royalty Funding Agreement
December 04, 2025
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Denali Therapeutics and Royalty Pharma Announce $275 Million Royalty Funding Agreement
December 04, 2025
From Denali Therapeutics Inc.
Via GlobeNewswire
News headline image
3 Mid-Cap Stocks That Concern Us
December 03, 2025
Via StockStory
News headline image
Royalty Pharma to Present at Upcoming Investor Conferences
November 26, 2025
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Why Ligand Pharma, A Hidden Name Behind Two Big Drugs, Is Up 88% This Year ↗
November 18, 2025
Via Investor's Business Daily
News headline image
3 Value Stocks with Warning Signs
November 17, 2025
Via StockStory
Topics Supply Chain
News headline image
3 Low-Volatility Stocks We Find Risky
November 16, 2025
Via StockStory
News headline image
Royalty Pharma (RPRX): Buy, Sell, or Hold Post Q3 Earnings?
November 12, 2025
Via StockStory
Topics Stocks Supply Chain
News headline image
Ligand Pharmaceuticals Soars to New Heights: A Deep Dive into its 52-Week High
November 06, 2025
Via MarketMinute
Topics Intellectual Property
News headline image
Royalty Pharma (NASDAQ:RPRX) Q3 2025 Earnings Beat Estimates and Raise Guidance ↗
November 05, 2025
Via Chartmill
Topics Earnings
News headline image
Stocks Rebound, Eli Lilly Jumps To 14-Month Highs: What's Moving Markets Wednesday? ↗
November 05, 2025
Via Benzinga
Topics Economy
News headline image
Royalty Pharma Reports Third Quarter 2025 Results
November 05, 2025
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Royalty Pharma Acquires Royalty Interest in Alnylam’s AMVUTTRA for $310 Million from Blackstone Life Sciences
November 04, 2025
From Royalty Pharma plc
Via GlobeNewswire
News headline image
Spotting Winners: Royalty Pharma (NASDAQ:RPRX) And Branded Pharmaceuticals Stocks In Q2
November 03, 2025
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
What To Expect From Royalty Pharma’s (RPRX) Q3 Earnings
November 03, 2025
Via StockStory
Topics Artificial Intelligence
News headline image
ROYALTY PHARMA PLC-CL A (RPRX) Shows Strong Technicals and a High-Quality Breakout Setup ↗
November 01, 2025
Via Chartmill

Frequently Asked Questions

Is Royalty Pharma plc - Class A Ordinary Shares publicly traded?
Yes, Royalty Pharma plc - Class A Ordinary Shares is publicly traded.
What exchange does Royalty Pharma plc - Class A Ordinary Shares trade on?
Royalty Pharma plc - Class A Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Royalty Pharma plc - Class A Ordinary Shares?
The ticker symbol for Royalty Pharma plc - Class A Ordinary Shares is RPRX on the Nasdaq Stock Market
What is the current price of Royalty Pharma plc - Class A Ordinary Shares?
The current price of Royalty Pharma plc - Class A Ordinary Shares is 40.26
When was Royalty Pharma plc - Class A Ordinary Shares last traded?
The last trade of Royalty Pharma plc - Class A Ordinary Shares was at 01/08/26 04:15 PM ET
What is the market capitalization of Royalty Pharma plc - Class A Ordinary Shares?
The market capitalization of Royalty Pharma plc - Class A Ordinary Shares is 15.63B
How many shares of Royalty Pharma plc - Class A Ordinary Shares are outstanding?
Royalty Pharma plc - Class A Ordinary Shares has 16B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap